Dr. Dunsmore is a program director in the NIGMS Division of Pharmacology, Physiology, and Biological Chemistry, where she oversees research grants in the areas of receptors, drug targets and signal transduction; sepsis and innate immunity; and inflammation. She serves as the program director for the Protocolized Care for Early Septic Shock (ProCESS) study, a large-scale trial to determine whether specific interventions can halt the progression to severe sepsis and septic shock. The project may establish the first set of standard procedures to diagnose and treat sepsis in emergency departments.
Prior to joining NIGMS in 2006, Dunsmore was a faculty member at Harvard Medical School and conducted pulmonary research in a laboratory based at Brigham and Women’s Hospital in Boston, MA.
To arrange an interview with Sarah Dunsmore, contact the NIGMS Office of Communications and Public Liaison at 301-496-7301.
Watch Sarah Dunsmore talk about sepsis.